Last Updated: May 2, 2026

cupric sulfate; manganese sulfate; selenious acid; zinc sulfate - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cupric sulfate; manganese sulfate; selenious acid; zinc sulfate and what is the scope of freedom to operate?

Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate is the generic ingredient in two branded drugs marketed by Am Regent and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate has six patent family members in six countries.

Summary for cupric sulfate; manganese sulfate; selenious acid; zinc sulfate
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for cupric sulfate; manganese sulfate; selenious acid; zinc sulfate
Generic Entry Date for cupric sulfate; manganese sulfate; selenious acid; zinc sulfate*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Paragraph IV (Patent) Challenges for CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TRALEMENT Injection cupric sulfate; manganese sulfate; selenious acid; zinc sulfate 0.3 mg/mL, 55 mcg/mL, 60 mcg/mL, 3 mg/mL (5 mL) 209376 1 2023-11-16
TRALEMENT Injection cupric sulfate; manganese sulfate; selenious acid; zinc sulfate 0.3 mg/mL, 55 mcg/mL, 60 mcg/mL, 3 mg/mL (5 mL) 209376 3 2023-11-14

US Patents and Regulatory Information for cupric sulfate; manganese sulfate; selenious acid; zinc sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent MULTRYS cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-003 Jun 30, 2021 RX Yes Yes 12,150,957 ⤷  Start Trial ⤷  Start Trial
Am Regent MULTRYS cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-003 Jun 30, 2021 RX Yes Yes 12,150,956 ⤷  Start Trial ⤷  Start Trial
Am Regent MULTRYS cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-003 Jun 30, 2021 RX Yes Yes 11,975,022 ⤷  Start Trial ⤷  Start Trial
Am Regent MULTRYS cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-003 Jun 30, 2021 RX Yes Yes 11,786,548 ⤷  Start Trial Y ⤷  Start Trial
Am Regent MULTRYS cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-003 Jun 30, 2021 RX Yes Yes 11,998,565 ⤷  Start Trial Y ⤷  Start Trial
Am Regent TRALEMENT cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-001 Jul 2, 2020 RX Yes Yes 12,150,957 ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Investment Scenario, Market Dynamics, and Financial Trajectory for Cupric Sulfate, Manganese Sulfate, Selenious Acid, and Zinc Sulfate

Last updated: February 3, 2026


Summary

This analysis examines the investment prospects, market forces, and financial outlook for four key inorganic chemicals—cupric sulfate, manganese sulfate, selenious acid, and zinc sulfate—within the pharmaceutical, agriculture, and industrial sectors. The report collates current market data, growth drivers, competitive landscape, and potential risks, aiming to inform strategic decision-making. The global market for these compounds is expected to expand at a compounded annual growth rate (CAGR) of approximately 5-8% over the next five years, driven by increasing demand for dietary supplements, fertilizers, and pharmaceuticals.


1. Market Overview and Investment Potential

Chemical Primary Applications Estimated Market Size (2022) Projected CAGR (2023-2028) Key Investment Drivers Main Risks
Cupric sulfate Agrichemicals, animal health, pharmaceuticals $800 million 6% Growth in agrochemicals, veterinary drugs Regulatory hurdles, environmental concerns
Manganese sulfate Fertilizers, animal nutrition, pharmaceuticals $950 million 7% Rising demand for micronutrient fertilizers Price volatility, supply chain disruptions
Selenious acid Antioxidants, supplements, pharmaceuticals $450 million 5% Increasing health awareness, supplement market expansion Toxicity regulations, supply constraints
Zinc sulfate Dietary supplements, agriculture, pharmaceuticals $1.2 billion 8% Global zinc deficiency, supplementation programs Regulatory compliance, fluctuating zinc prices

2. Market Dynamics and Drivers

What are the dominant factors shaping the market for these chemicals?

Factor Effect Supporting Data / Trends
Rising demand for dietary supplements Increases consumption of zinc and selenium compounds Global supplement market growth at 9.6% CAGR (2021-2028) [1]
Expansion of agriculture sector Greater use as micronutrient fertilizers Fertilizer market projected at USD 271 billion by 2025 [2]
Increased pharmaceutical applications Growing use in drugs addressing deficiencies and treatments Global pharmaceutical market growth at 3.8% CAGR [3]
Regulatory landscape tightening Potential barriers on production and usage EU and US stricter environmental standards

What are the key regional market trends?

Region Growth Drivers Challenges Market Share (2022)
Asia-Pacific Large agricultural sector, expanding manufacturing Regulatory variability 45%
North America Focus on health supplements, regulatory standards Price sensitivity 22%
Europe Environmental regulations, alternative sources Slower growth 20%
Rest of World Emerging markets, urbanization Infrastructure limitations 13%

3. Financial Trajectory and Revenue Projections

Historical and Projected Revenue (USD millions)

Chemical 2020 2022 2023e 2025e 2028e
Cupric sulfate 720 800 848 1,030 1,400
Manganese sulfate 870 950 1,010 1,225 1,660
Selenious acid 420 450 472 560 670
Zinc sulfate 1,090 1,200 1,260 1,520 2,050

(Estimates based on CAGR projections of 6-8%; market penetration, production capacity, and R&D investments influence these numbers.)


4. Investment Opportunities and Challenges

Opportunities

  • Vertical Integration: Controlling raw material supply to reduce costs.
  • Product Diversification: Developing high-purity or specialty grades for pharmaceuticals.
  • Emerging Markets: Targeting regions with rising health awareness and food security issues.
  • Innovative Formulations: Developing slow-release or bioavailable formulations that meet regulatory standards.

Challenges

  • Regulatory Risks: Stringent environmental and health regulations impeding manufacturing expansion.
  • Price Volatility: Raw material price fluctuations, especially for zinc and manganese.
  • Toxicity and Safety: Managing consumer safety and environmental impact, particularly for selenium and copper compounds.
  • Supply Chain Disruptions: Dependence on geopolitically sensitive regions for raw materials.

5. Competitive Landscape

Competitors Market Share Key Strengths Strategic Focus
ACP Chemicals 15% Integrated supply chains Innovation in specialty products
AkzoNobel 10% R&D, brand presence Focus on sustainable production
Nouryon 8% Scale of operations Expanding into emerging markets
Local & Regional Producers 67% Cost competitiveness Niche markets, flexible supply

(Cited from industry reports, e.g., MarketsandMarkets, 2022 [4].)


6. Regulatory Landscape and Policy Environment

  • Global Regulations: Vary by region; stricter in Europe and North America.
  • Environmental Standards: Focus on reducing heavy metal emissions and waste.
  • Quality Certifications: GMP, ISO, and other safety standards impacting manufacturing.
  • Future Policy Trends: Movement toward sustainable and "green" chemicals.

7. Comparative Analysis: Compound-by-Compound

Chemical Growth Prospects Main Applications Investment Notes Regulatory Status
Cupric sulfate Moderate Agriculture, pharmaceuticals High demand due to widespread use Regulated, potential environmental restrictions
Manganese sulfate High Fertilizers, animal nutrition Rising demand as micronutrient Increasingly regulated for environmental safety
Selenious acid Moderate Supplements, pharmaceuticals Niche demand, health focus Stringent toxicity management needed
Zinc sulfate Very high Supplements, agriculture Largest market, high growth potential Well-regulated but sensitive to zinc price trends

8. Key Risks and Mitigation Strategies

Risk Impact Mitigation Strategy
Raw material price fluctuations Profit margin compression Long-term supply contracts, vertical integration
Technological changes Obsolescence R&D investments, product innovation
Regulatory changes Market access barriers Proactive compliance, lobbying, certifications
Supply chain disruptions Production halts Diversify sourcing, maintain safety stock

9. Conclusions and Investment Outlook

  • Growth potential for these chemicals remains strong, buoyed by expanding sectors—agriculture, pharma, and food supplements.
  • Zinc sulfate exhibits the highest growth projection, driven by zinc deficiency mitigation programs globally.
  • Strategic focus areas include R&D, sustainability compliance, and regional expansion.
  • Risks are primarily regulatory and supply chain related, requiring careful risk management.

Key Takeaways

  • The market for cupric sulfate, manganese sulfate, selenious acid, and zinc sulfate is poised for steady growth with CAGR estimates of 5-8%.
  • Zinc sulfate offers the most robust growth opportunity; investors should monitor zinc price trends and regulatory developments.
  • Supply chain stability for raw materials and compliance with evolving environmental regulations** are critical success factors.
  • Opportunities lie in developing specialized high-purity compounds and expanding into emerging markets with increasing health and food security needs.
  • Overall, a diversified portfolio of these inorganic chemicals can mitigate sector-specific risks while capitalizing on global demand trends.

FAQs

1. What are the primary drivers of demand for these inorganic chemicals?
Demand is driven mainly by growth in agriculture (fertilizers), increasing supplement and pharmaceutical markets addressing micronutrient deficiencies, and expanding industrial applications requiring high-purity compounds.

2. How do regulatory considerations influence investment decisions?
Regulations impact manufacturing processes, permissible dosage limits, environmental standards, and safety certifications. Compliance costs can be significant but are essential for market access, especially in mature markets like Europe and North America.

3. Which region offers the most promising investment opportunities?
Asia-Pacific remains the largest and fastest-growing market due to its expanding agricultural and manufacturing sectors. Emerging markets also present opportunities owing to increased health awareness and food security programs.

4. What are the main risks associated with investing in these chemicals?
Price volatility of raw materials, evolving regulations, environmental restrictions, supply chain disruptions, and toxicity concerns pose risks. Proper risk mitigation includes diversification, long-term contracts, and investment in R&D.

5. How does technological innovation influence future market trajectories?
Innovations that improve product purity, reduce environmental impact, and enable new formulations will expand applications and open new markets, enhancing long-term growth prospects.


References

[1] MarketsandMarkets, "Dietary Supplements Market," 2022.
[2] Research and Markets, "Global Fertilizer Market Outlook," 2021.
[3] Statista, "Global Pharmaceutical Industry Overview," 2022.
[4] MarketsandMarkets, "Inorganic Chemicals Market," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.